Write For Us

Pfizer begins study of oral drug for prevention of COVID-19

E-Commerce Solutions SEO Solutions Marketing Solutions
48 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Pfizer Inc said on Monday it has started a large study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus.

The drugmaker and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG, have been racing to develop an easy-to-administer antiviral pill for COVID-19.

The mid-to-late-stage study will test Pfizer's drug, PF-07321332, in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic COVID-19 infection.

Source: Reuters
Category
TV Saluran - TV Channel
Tags
kinitv, malaysia, politics
Sign in or sign up to post comments.
Be the first to comment